Clinical Trial Update: Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation [NA]

View source ↗

Summary

Clinical trial update on a coating designed to optimize treatment with a new generation Flow Diverter for intracranial aneurysm, sponsored by Phenox GmbH; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm

Drugs mentioned

• Phenox Flow Diverter (Flow-diverting stent)

Snippet

Sponsor: Phenox GmbH | Conditions: Intracranial Aneurysm | NA | Status: ACTIVE_NOT_RECRUITING